Steffen Schmitz-Valckenberg, Acucela (F), Allergan (F), Allergan (C), Apellis (C), Bayer (F), Bioeq (F), Bioeq/Formycon (C), Carl Zeiss MediTec (F), Carl Zeiss MediTec (R), Centervue (F), Galimedix (C), Heidelberg Engineering (F), Katairo (F), Novartis (C), Novartis (R), Novartis (F), Optos (F), Oxurion (C), Roche (F), Roche (R);
Zhichao Wu, None;
Maximilian Pfau, Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Optos (F);
Barbara Blodi, None;
Frank Holz, Acucela (F), Acucela (R), Allergan (F), Allergan (C), Apellis (C), Apellis (R), Bayer (C), Bayer (F), Bayer (R), Bioeq/Formycon (C), Bioeq/Formycon (F), Boehringer-Ingelheim (C), Centervue (F), Ellex (R), Geuder (C), Grayburg Vision (C), Grayburg Vision (R), Heidelberg Engeering (C), Heidelberg Engineering (F), Heidelberg Engineering (R), IvericBIO (C), Roche/Genentech (C), Roche/Genentech (F), Roche/Genentech (R);
Petrus Chang, Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Optos (F);
Glenn Jaffe, Allegro (C), Iveric (C), Novartis (C), Regeneron (C);
Sandra Liakopoulos, Allergan (R), Bayer (C), Bayer (R), Heidelberg Engineering (R), Novartis (C), Novartis (F), Novartis (R), Santhera (R), Zeiss (R);
Srinivas Sadda, 4DMT (C), 4DMT (R), Allergan (R), Allergan (C), Amgen (R), Amgen (C), Bayer (R), Carl Zeiss MediTec (F), Carl Zeiss MediTec (R), Centervue (F), Centervue (R), Heidelberg Engineering (F), Nidek (F), Nidek (R), Novartis (C), Novartis (R), Optos (F), Oxurion (C), Oxurion (R), Regeneron (C), Regeneron (R), Roche/Genentech (C), Roche/Genentech (R), Topcon (F), Topcon (R);
Giovanni Staurenghi, Alcon (R), Allergan (R), Bayer (C), Bayer (R), Boehringer Ingelheim (R), Carl Zeiss Meditec (C), Carl Zeiss Meditec (R), Carl Zeiss MediTec (F), Centervue (C), Centervue (F), Centervue (R), Heidelberg Engineering (C), Heidelberg Engineering (R), Nidek (F), Novartis (F), Novartis (C), Novartis (R), Optos (F), Optos (R), Optovue (F);
Robyn Guymer, Apellis (C), Bayer (C), Genentech/Roche (C), Novartis (C)